GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...

Despite increasing artificial intelligence use for healthcare from patients and providers alike, a new study from Mass ...

OpenAI rolled out their updated Codex app for Mac yesterday and, among other things, they shipped a native computer use tool ...

OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...

OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research ...

In an era where AI systems are rapidly scaling beyond the limits of traditional silicon, new experimental companies are ...

Artificial intelligence is already proving it can accelerate drug development and improve our understanding of disease. But ...

Meta's new hyperagent framework breaks the AI "maintenance wall," allowing systems to autonomously rewrite their own logic ...

SCS research institutes and centers play a key role in convening interdisciplinary talent across our academic departments, government and industry to develop technology that will impact generations to ...

The models are designed to predict someone’s risk of diabetes or stroke. A few might already have been used on patients.

Nvidia (NVDA) stock advances following the release of open-source Ising quantum AI models designed to enhance calibration ...